Table 1 Clinical data and demographics of patients
Variable | Numerical value |
|---|---|
Mean age (years) | 62.86 |
Sex (case) | |
 Male | 1574 (67.99%) |
 Female | 741 (32.01%) |
NYHA functional class (case) | |
 I | 1795 (77.54%) |
 II | 172 (7.43%) |
 III | 280 (12.09%) |
 IV | 68 (2.94%) |
Average number of days in hospital (days) | |
 NYHA I | 6.25 |
 NYHA II | 10.16 |
 NYHA III | 13.57 |
 NYHA IV | 12.91 |
Medication (case) | |
 B-blocker | 1828 (78.96%) |
 Diuretic | 1987 (85.83%) |
 ACE inhibitor | 489 (21.12%) |
 Angiotensin Receptor inhibitor | 1567 (67.69%) |
 Digitalis | 568 (24.54%) |
 Mineralocorticoid receptor antagonist | 1670 (72.14%) |
 Sacubitril valsartan | 874 (37.75%) |
Comorbidities (case) | |
 Hypertension | 1456 (62.89%) |
 Diabetes mellitus | 678 (29.29%) |
 Atrial fibrillation | 436 (18.83%) |
 Coronary heart disease | 1034 (44.67%) |
 Cardiac valve disease | 409 (17.67%) |
 Cardiomyopathy | 103 (4.45%) |